Abstract:IL-36 cytokines are emerging as beneficial in immunity against pathogens and cancers but can also be detrimental when dysregulated in autoimmune and autoinflammatory conditions. Interest in targeting IL-36 activity for therapeutic purposes is rapidly growing, yet many unknowns about the functions of these cytokines remain. Thus, the availability of robust research tools is essential for both fundamental basic science and pre-clinical studies to fully access outcomes of any manipulation of the system. For this purpose, a floxed Il1rl2, the gene encoding the IL-36 receptor, mouse strain was developed to facilitate the generation of conditional knockout mice. The targeted locus was engineered to contain an inverted mCherry reporter sequence that upon Cre-mediated recombination will be flipped and expressed under the control of the endogenous Il1rl2 promoter. This feature can be used to confirm knockout in individual cells but also as a reporter to determine which cells express the IL-36 receptor IL-1RL2. The locus was confirmed to function as intended and further used to demonstrate the expression of IL-1RL2 in barrier tissues. Il1rl2 expression was detected in leukocytes in all barrier tissues. Interestingly, strong expression was observed in epithelial cells at locations in direct contact with the environment such as the skin, oral mucosa, the esophagus, and the upper airways, but almost absent from epithelial cells at more inward facing sites, including lung alveoli, the small intestine, and the colon. These findings suggest specialized functions of IL-1RL2 in outward facing epithelial tissues and cells. The generated mouse model should prove valuable in defining such functions and may also facilitate basic and translational research.

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer.

Biological functions and clinical implications of interleukin-34 in inflammatory diseases

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

IL-34 and CSF-1: similarities and differences

Neuron Derived Cytokine Interleukin-34 Controls Developmental Microglia Function

CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis

The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1

The Critical Role Of Il-34 In Osteoclastogenesis

iRhom2 regulates CSF1R cell surface expression and non-steady state myelopoiesis in mice

Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration

Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival

IL-3 plays a critical role in development of dendritic cells from murine hematopoietic progenitor cells of fetal liver

Perinatal brain group 3 innate lymphoid cells are involved in the formation of murine dural lymphatics

IL-34 empowers regulatory T cells with novel non-canonical function to safeguard brain barrier integrity during neuro-inflammation.

CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages

Cutting Edge: CCR8 Signaling Regulates IL-25- and IL-33-Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function

CSF-1 controls cerebellar microglia and is required for motor function and social interaction

Floxed Il1rl2 Locus with mCherry Reporter Element Reveals Distinct Expression Patterns of the IL-36 Receptor in Barrier Tissues

[Colony-Stimulating Factor-1 Receptor in Rat Dental Follicle Cells].

Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models